Stock listing
Nexentis Technologies Inc.
Selected listing: A425ME · LS · EUR · DE
Nexentis Technologies Inc. (Lang & Schwarz: A425ME), Consumer Non-Durables. Latest release Sep 23, 2026: Nexentis: MitoCareX Evaluates Expanded Protein…
- Ticker
- Lang & Schwarz: A425ME
- Asset type
- Stock
- Sector
- Consumer Non-Durables
- Industry
- Household/Personal Care
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Nexentis Technologies Inc.
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
September 23, 2026
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign
July 28, 2026
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative
July 7, 2026
Nexentis Announces Monetization of Part of its Melz Solar Investment at $14.5 Million Project Valuation – Significant Premium to Initial Investment
June 29, 2026
Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
June 21, 2026
Research Nexentis Technologies Inc.
Nexentis Technologies Inc. company profile
View the public company page for Nexentis Technologies Inc. on 6ix.
Nexentis Technologies Inc. news
Read company news and market updates connected to Nexentis Technologies Inc..
Nexentis Technologies Inc. investor events
Find investor webinars, events, and replay context for Nexentis Technologies Inc..
Alternate listings
NXTS:NASDAQ
US · USD
Alternate listing for Nexentis Technologies Inc.; the primary context on this page is A425ME:LS.
NXTS:BOATS
US · USD
Alternate listing for Nexentis Technologies Inc.; the primary context on this page is A425ME:LS.
80W0:MUN
DE · EUR
Alternate listing for Nexentis Technologies Inc.; the primary context on this page is A425ME:LS.